Mark Hokenson

Mark Hokenson has extensive work experience in the pharmaceutical and biotech industry. Mark currently serves as the Director of Formulation Development at Receptor Life Sciences, Inc., where they lead R&D activities in developing analytical methods and formulating drug candidates. Mark also developed and managed a Quality program to support Phase 1 GMP activities.

Prior to their current role, Mark worked at Pharmavite as the Manager of Analytical, overseeing the development, validation, and transfer of analytical methods for testing vitamins and dietary supplements. Mark also managed the real-time stability program and collaborated with USP to ensure product quality.

Mark's previous experience includes working at Integrity Bio, Inc. as the Director of Formulation Development, where they played a key role in developing formulations. Mark also held the position of Senior Scientist at Integrity Bio, Inc.

Before joining Integrity Bio, Inc., Mark worked as a Consultant providing analytical and biophysical services at PerQFlo, LLC. Mark also served as a Senior Scientist at MannKind Corporation, where they contributed to scientific research and development.

Mark's academic background includes serving as a Post-Doctoral Protein Chemist at the University of California, Santa Cruz. Mark also pursued graduate studies at the same university, specializing in protein chemistry.

Overall, Mark Hokenson has demonstrated expertise in formulation development, analytical methods, quality management, and scientific research.

Mark Hokenson received a Bachelor of Science degree in Chemistry from California State Polytechnic University-Pomona, where they studied from 1991 to 1997. Following this, they pursued a PhD in Biochemistry at the University of California, Santa Cruz, from 1997 to 2002.